603 related articles for article (PubMed ID: 17214375)
21. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.
Parr C; Gan CH; Watkins G; Jiang WG
Angiogenesis; 2006; 9(2):73-81. PubMed ID: 16758268
[TBL] [Abstract][Full Text] [Related]
22. New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase.
Sasano H; Nagasaki S; Miki Y; Suzuki T
Ann N Y Acad Sci; 2009 Feb; 1155():76-9. PubMed ID: 19250194
[TBL] [Abstract][Full Text] [Related]
23. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK
Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin expression profiles predict pathological and clinical outcome in breast cancer.
Patani N; Jouhra F; Jiang W; Mokbel K
Anticancer Res; 2008; 28(6B):4105-10. PubMed ID: 19192668
[TBL] [Abstract][Full Text] [Related]
25. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.
Chhabra A; Fernando H; Watkins G; Mansel RE; Jiang WG
Oncol Rep; 2007 Oct; 18(4):953-8. PubMed ID: 17786359
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer.
Salhab M; Singh-Ranger G; Mokbel R; Jouhra F; Jiang WG; Mokbel K
J Surg Oncol; 2007 Oct; 96(5):424-8. PubMed ID: 17657731
[TBL] [Abstract][Full Text] [Related]
27. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
[TBL] [Abstract][Full Text] [Related]
28. The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters.
Wazir U; Jiang WG; Sharma AK; Mokbel K
Anticancer Res; 2012 Feb; 32(2):671-4. PubMed ID: 22287761
[TBL] [Abstract][Full Text] [Related]
29. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis].
Li HX; Zh S; Zhang YH; Risberg B; Karlsson MG; Nesland JM
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):669-72. PubMed ID: 15777505
[TBL] [Abstract][Full Text] [Related]
30. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
31. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.
Lane J; Martin TA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2008 Sep; 33(3):585-93. PubMed ID: 18695890
[TBL] [Abstract][Full Text] [Related]
32. HDAC6 expression is correlated with better survival in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H
Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975
[TBL] [Abstract][Full Text] [Related]
33. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
34. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
[TBL] [Abstract][Full Text] [Related]
35. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
36. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
Mita K; Zhang Z; Ando Y; Toyama T; Hamaguchi M; Kobayashi S; Hayashi S; Fujii Y; Iwase H; Yamashita H
Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285
[TBL] [Abstract][Full Text] [Related]
38. HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
Mansfield L; Subramanian A; Devalia H; Jiang W; Newbold RF; Mokbel K
Anticancer Res; 2007; 27(4B):2265-8. PubMed ID: 17695512
[TBL] [Abstract][Full Text] [Related]
39. The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer.
Kostadima L; Pentheroudakis G; Pavlidis N
Anticancer Res; 2007; 27(4B):2499-504. PubMed ID: 17695545
[TBL] [Abstract][Full Text] [Related]
40. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
